Consistent with prior work showing the blocking of the classic RAS axis for the treatment of hypertension [37,38], GSNO-loaded nanoparticles protected against hypertension coinciding with the reduced expression of renin, ACE1, and AT1R in the kidneys. Here, ACE is linked to hypertensive disorder.